CJ

Chinese Journal Of Cancer Research

Chinese Journal of Cancer Research is a cancer-focused journal publishing review articles, original articles, commentaries, correspondence, and guideline-related content, including National Health Commission and CSCO guidelines. The homepage highlights current issues, in press content, special issues, virtual special issues, online submission, and a 2024 Impact Factor of 6.3.

Looking to publish in Chinese Journal Of Cancer Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 6.3
Quartile Q1
Open Access Type Open
ISSN 1000-9604
eISSN 1993-0631
Invitation Only No

Submission Instructions

Chinese Journal Of Cancer Research accepts the following article types. Click on an article type to view submission instructions.

Original Articles

Cover Letter A cover letter is required. The cover letter must acknowledge that all authors contributed significantly and agree with the manuscript content.
Abstract An abstract is required. Abstract must not exceed 300 words. Abstract must be structured. Abstract must use the headings Objective, Methods, Results, and Conclusions.
Manuscript Manuscript must not exceed 5,000 words excluding the title page, abstract, references, figures, figure legends, and tables. Original Articles should normally be organized as Introduction, Materials and Methods, Results, and Discussion. The manuscript must include three to six MeSH keywords, an Author contributions section, and a disclosure statement.
References References must use the Vancouver system. References must be cited as superscript Arabic numerals in order of appearance, and the reference list must list all authors if there are three or fewer or the first three followed by et al. if there are four or more.
Figures & Tables Each figure must be uploaded as an individual file separate from the manuscript, while tables must be typed on separate pages. Figures and tables must be numbered consecutively in Arabic numerals, and each figure must have a caption on a separate page.
Reformat to Chinese Journal Of Cancer Research using Livewrite Premium

Review Articles

Cover Letter Cover letter is required. Cover letter must acknowledge that all authors contributed significantly and agree with the manuscript content.
Abstract Abstract is required. Abstract must not exceed 300 words. Abstract must be structured. Abstract must include the headings Objective, Methods, Results, and Conclusions.
Manuscript Manuscript must not exceed 5,000 words excluding the title page, abstract, references, figures, figure legends, and tables. Review article text may be organized into several sections with headings as suitable rather than the specifically outlined Original Article sections. Manuscript must include three to six MeSH keywords below the abstract in alphabetical order and an Author contributions section.
References References must use the Vancouver system. References must be cited with superscript Arabic numerals in order of appearance, and the reference list must list all authors when there are three or fewer or the first three followed by et al. when there are four or more.
Figures & Tables Each figure must be uploaded as an individual file separate from the manuscript, while tables must be typed on separate pages. Figures and tables must be numbered consecutively in Arabic numerals, and each figure must have a caption on a separate page.
Reformat to Chinese Journal Of Cancer Research using Livewrite Premium

Recent Publications

From spatial maps to therapeutic targets: Next challenge for artificial intelligence in cancer spatial omics

Xu Hui, Zhang Yuyuan, Ren Yuqing, Luo Peng, Zhu Haidong

10.21147/j.issn.1000-9604.2026.02.06
View Publication

Refined immune-based molecular subtypes of gastric cancer: Integrating mismatch repair status and tumor microenvironment for enhanced immunotherapy prediction

Shen Ke, Zhang Yanqiang, Wang Zhiqin, Xu Ruixing, He Jintao, Zhou Mengya, Lu Yiming, Zhu Danni, Wei Yizhou, Zhu Weiwei, Yang Qing, Xu Zhiyuan, Hu Can, Pan Siwei, Cheng Xiangdong

10.21147/j.issn.1000-9604.2026.02.09
View Publication

Development of an interpretable machine learning model for lymphovascular space invasion prediction in patients with endometrioid endometrial carcinoma: A prospective study

Wu Meixuan, Zhou Ling, Yang Xiao, Yang Sihui, Sun Bowen, Zhai Lirong, Li Chengcheng, Zhou,Yuan Cheng Huaijun, Wang Jianliu

10.21147/j.issn.1000-9604.2026.02.10
View Publication

CARE framework: Rethinking randomized controlled trials for medical artificial intelligence

Yang Sicheng, Yang Qiuxia, Mao Yize, Zhu Lei

10.21147/j.issn.1000-9604.2026.02.05
View Publication

Revisiting nature of stage III non-small cell lung cancer: Anatomically defined, biologically systemic

Li Guoyin, Zhang Xi, Fu Xiaolu, Liu Xuewen, Song Zewen

10.21147/j.issn.1000-9604.2026.02.08
View Publication

Research Topics

Gastric Cancer Management and Outcomes Cancer-related Molecular Pathways Esophageal Cancer Research and Treatment Lung Cancer Treatments and Mutations RNA modifications and cancer Immunotherapy and Immune Responses Hepatocellular Carcinoma Treatment and Prognosis Cancer Research and Treatments Virus-based gene therapy research Breast Cancer Treatment Studies Monoclonal and Polyclonal Antibodies Research Cancer, Hypoxia, and Metabolism Cancer Immunotherapy and Biomarkers Glycosylation and Glycoproteins Research Lung Cancer Diagnosis and Treatment Cholangiocarcinoma and Gallbladder Cancer Studies Lymphoma Diagnosis and Treatment Immune Cell Function and Interaction Gastrointestinal Tumor Research and Treatment Metastasis and carcinoma case studies Head and Neck Cancer Studies Helicobacter pylori-related gastroenterology studies Cancer-related gene regulation RNA Interference and Gene Delivery HER2/EGFR in Cancer Research

Related Journals

JO
Journal Of The National Comprehensive Cancer Network National Comprehensive Cancer
CA
Clinical And Translational Medicine Springer Science+Business Media
JO
Journal Of Thoracic Oncology Elsevier BV
Le
Leukemia Springer Nature
Bi
Biodrugs Adis, Springer Healthcare
JO
Journal Of Chemotherapy Taylor & Francis